Complete Filing Data
Eledon Pharmaceuticals, Inc. reported Stockholders Equity of $81.09 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Eledon Pharmaceuticals, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$45.6M | -$36.2M | -$116.5M | -$88.0M | -$34.5M | -$22.8M | -$16.0M | -$14.1M | -$13.1M | -$5.7M | -$45.1M | -$23.3M | -$15.7M | -$9.6M |
| Operating Income Loss | -$43.0M | -$88.4M | -$36.9M | -$18.5M | -$16.1M | -$14.1M | -$13.1M | -$5.1M | -$45.3M | -$23.5M | -$15.7M | -$9.6M | ||
| Research And Development Expense | $66.3M | $52.0M | $30.3M | $27.1M | $23.7M | $6.1M | $8.1M | $6.8M | $2.0M | $3.2M | $32.6M | $14.6M | $12.2M | $7.4M |
| Operating Expenses | $83.3M | $70.6M | $43.0M | $88.4M | $36.9M | $18.5M | $16.1M | $14.1M | $13.1M | $5.1M | $45.3M | $23.5M | $15.7M | $9.6M |
| General And Administrative Expense | $17.0M | $18.6M | $12.7M | $12.7M | $13.1M | $10.1M | $6.1M | $7.2M | $11.1M | $1.9M | $12.6M | $8.9M | $3.5M | $2.3M |
| Other Nonoperating Income Expense | $4.2M | $3.9M | $2.7M | $462.0K | $7.0K | $79.0K | $40.0K | -$5.0K | $5.0K | -$527.0K | ||||
| Sales Revenue Goods Net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| In Process Research And Development | $32.4M | $32.4M | $32.4M | $32.4M | $32.4M | $32.4M | ||||||||
| Deferred Income Tax Liabilities Net | $2.2M | $2.2M | $1.8M | $1.8M | $1.8M | $4.1M | ||||||||
| Comprehensive Income Net Of Tax | -$45.6M | -$36.2M | -$37.9M | -$45.1M | -$23.3M | -$15.7M | ||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$45.6M | -$35.8M | -$116.5M | -$88.0M | -$36.9M | -$23.2M | -$16.0M | |||||||
| Net Income Loss Available To Common Stockholders Basic | -$45.1M | -$23.3M | -$15.8M | -$9.7M | ||||||||||
| Income Tax Expense Benefit | $35.0K | $431.0K | $0.00 | $0.00 | -$2.4M | -$404.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$17.5M | -$11.2M | -$6.5M | $77.0M | -$44.9M | -$23.6M | -$9.9M | -$65.8M | -$10.8M | -$10.5M | -$9.2M | -$9.9M | -$9.8M | -$7.4M | -$8.5M | -$6.1M | -$2.6M | -$8.2M | -$2.9M | -$4.1M | -$4.9M | -$3.5M | -$3.2M | -$2.8M | -$3.0M | -$6.7M | -$1.4M | -$3.7M | -$2.0M | -$1.0M | -$11.4M | -$11.0M | -$11.9M | -$9.0M | -$13.3M | -$6.2M | -$6.4M | -$5.9M | -$4.8M | -$5.5M | -$3.4M | -$4.4M | -$2.4M |
| Operating Income Loss | -$19.1M | -$24.7M | -$18.0M | -$20.5M | -$14.5M | -$10.9M | -$11.2M | -$10.4M | -$11.1M | -$10.6M | -$9.3M | -$9.9M | -$10.5M | -$8.0M | -$9.0M | -$6.1M | -$2.6M | -$3.4M | -$2.9M | -$4.1M | -$4.9M | -$3.5M | -$3.2M | -$2.8M | -$3.0M | -$6.7M | -$1.4M | -$3.8M | -$1.6M | -$932.0K | -$11.5M | -$11.1M | -$11.9M | -$9.0M | -$13.3M | -$6.3M | -$6.4M | -$5.9M | -$4.9M | -$5.5M | -$3.4M | -$4.4M | -$2.4M |
| Research And Development Expense | $15.0M | $20.3M | $13.5M | $16.5M | $10.1M | $7.4M | $7.9M | $7.2M | $8.1M | $7.5M | $5.7M | $6.6M | $7.7M | $4.2M | $5.7M | $615.0K | $832.0K | $1.6M | $1.5M | $2.3M | $3.0M | $1.7M | $1.3M | $1.1M | $517.0K | $533.0K | $479.0K | $1.1M | $592.0K | $7.9M | $8.5M | $5.9M | $10.6M | $2.8M | $4.4M | $3.6M | $2.7M | ||||||
| Operating Expenses | $19.1M | $24.7M | $18.0M | $20.5M | $14.5M | $10.9M | $11.2M | $10.4M | $11.1M | $10.6M | $9.3M | $9.9M | $10.5M | $8.0M | $9.0M | $6.1M | $2.6M | $3.4M | $2.9M | $4.1M | $4.9M | $3.5M | $3.2M | $2.8M | $3.0M | $6.7M | $1.4M | $1.6M | $932.0K | $11.5M | $11.9M | $9.0M | $13.3M | $6.4M | $5.9M | $4.9M | $3.4M | ||||||
| General And Administrative Expense | $4.1M | $4.5M | $4.4M | $4.0M | $4.4M | $3.5M | $3.3M | $3.2M | $3.0M | $3.1M | $3.5M | $3.2M | $2.8M | $3.7M | $3.4M | $3.7M | $1.3M | $1.7M | $1.4M | $1.8M | $1.9M | $1.8M | $1.9M | $1.7M | $2.4M | $6.1M | $906.0K | $564.0K | $340.0K | $3.5M | $3.4M | $3.1M | $2.7M | $3.6M | $1.5M | $1.3M | $661.0K | ||||||
| Other Nonoperating Income Expense | $1.0M | $1.2M | $1.4M | $1.0M | $869.0K | $574.0K | $849.0K | $775.0K | $338.0K | $127.0K | $36.0K | -$5.0K | $3.0K | -$1.0K | $5.0K | $4.0K | $5.0K | $30.0K | $27.0K | -$4.0K | -$6.0K | $3.0K | -$11.0K | -$5.0K | $4.0K | $11.0K | -$418.0K | -$70.0K | $34.0K | ||||||||||||||
| Sales Revenue Goods Net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||
| In Process Research And Development | $32.4M | $32.4M | $32.4M | $32.4M | $32.4M | $32.4M | $32.4M | $32.4M | $32.4M | $32.4M | $32.4M | $32.4M | $32.4M | $32.4M | $32.4M | $32.4M | |||||||||||||||||||||||||||
| Deferred Income Tax Liabilities Net | $2.2M | $2.2M | $2.2M | $1.8M | $1.8M | $1.8M | $1.8M | $1.8M | $1.8M | $1.8M | $1.8M | $1.8M | $2.3M | $3.0M | $3.6M | ||||||||||||||||||||||||||||
| Comprehensive Income Net Of Tax | -$17.4M | -$11.2M | -$6.5M | $77.1M | -$44.9M | -$23.6M | -$9.9M | -$3.9M | -$9.3M | -$13.5M | -$11.4M | -$11.8M | -$9.0M | -$13.3M | -$6.4M | -$5.9M | |||||||||||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$10.5M | -$9.2M | -$9.9M | -$10.5M | -$8.0M | -$9.0M | -$6.1M | -$2.6M | -$8.2M | ||||||||||||||||||||||||||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$16.1M | $54.4M | -$9.9M | -$6.2M | -$6.4M | -$5.9M | -$4.8M | -$5.5M | -$3.4M | -$4.5M | -$2.4M | ||||||||||||||||||||||||||||||||
| Income Tax Expense Benefit | -$686.0K | -$588.0K | -$501.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $81.1M | $62.4M | -$48.5M | $84.2M | $164.0M | $190.6M | $9.5M | $14.5M | $19.5M | -$2.7M | $2.8M | $103.5M | -$55.3M | -$39.9M | -$30.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $22.8M | $20.5M | $4.6M | $56.4M | $84.8M | $114.2M | $8.8M | $13.0M | $17.3M | $1.1M | $3.1M | ||||
| Cash And Cash Equivalents At Carrying Value | $22.8M | $20.5M | $4.6M | $56.4M | $84.8M | $114.2M | $8.8M | $13.0M | $17.2M | $1.1M | $105.3M | $31.8M | $11.7M | $2.3M | |
| Retained Earnings Accumulated Deficit | -$401.2M | -$355.6M | -$319.4M | -$202.9M | -$114.9M | -$80.4M | -$57.6M | -$41.6M | -$27.5M | -$14.4M | -$131.4M | -$86.4M | -$63.1M | ||
| Liabilities | $32.2M | $59.3M | $81.9M | $8.6M | $6.6M | $6.6M | $1.5M | $2.5M | $1.4M | $3.9M | $6.3M | $4.2M | $2.2M | ||
| Common Stock Value | $75.0K | $60.0K | $24.0K | $14.0K | $14.0K | $15.0K | $1.0K | $9.0K | $7.0K | $23.0K | $22.0K | ||||
| Prepaid Expense And Other Assets Current | $2.4M | $3.6M | $5.0M | $3.1M | $3.5M | $1.4M | $1.2M | $1.3M | $1.7M | $33.0K | $3.2M | $2.3M | $425.0K | ||
| Liabilities And Stockholders Equity | $169.0M | $177.4M | $89.1M | $92.8M | $170.5M | $197.2M | $10.9M | $17.0M | $20.9M | $1.2M | $68.0M | $107.7M | $32.3M | ||
| Assets Current | $135.7M | $143.7M | $56.1M | $59.5M | $88.3M | $115.6M | $10.0M | $14.3M | $19.0M | $1.2M | $67.2M | $107.5M | $32.2M | ||
| Assets | $169.0M | $177.4M | $89.1M | $92.8M | $170.5M | $197.2M | $10.9M | $17.0M | $20.9M | $1.2M | $68.0M | $107.7M | $32.3M | ||
| Additional Paid In Capital Common Stock | $482.2M | $417.9M | $326.6M | $287.0M | $278.9M | $271.0M | $67.0M | $56.1M | $47.0M | $11.4M | $193.2M | $189.8M | |||
| Accounts Payable Current | $3.6M | $5.8M | $967.0K | $2.2M | $1.8M | $1.4M | $329.0K | $689.0K | $418.0K | $338.0K | $1.2M | $765.0K | $5.0K | ||
| Liabilities Current | $18.3M | $11.6M | $3.9M | $6.5M | $4.4M | $2.5M | $1.3M | $2.5M | $6.2M | $4.2M | $2.2M | ||||
| Other Assets Noncurrent | $322.0K | $363.0K | $186.0K | $150.0K | $400.0K | $383.0K | $639.0K | $869.0K | $15.0K | $45.0K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $2.3M | $15.9M | -$51.8M | -$28.4M | -$29.4M | $105.4M | -$4.2M | -$4.3M | $16.2M | -$2.0M | |||||
| Accrued Liabilities And Other Liabilities | $14.4M | $5.4M | $2.5M | $3.9M | $2.2M | $973.0K | $813.0K | $1.8M | $354.0K | $113.0K | |||||
| Operating Lease Right Of Use Asset | $613.0K | $926.0K | $365.0K | $739.0K | $768.0K | $138.0K | $316.0K | ||||||||
| Operating Lease Liability Current | $358.0K | $314.0K | $383.0K | $363.0K | $369.0K | $144.0K | $180.0K | ||||||||
| Property Plant And Equipment Net | $5.0K | $14.0K | $25.0K | $31.0K | $489.0K | $33.0K | $29.0K | ||||||||
| Amortization Of Operating Lease Asset | $374.0K | $373.0K | $195.0K | $178.0K | $173.0K | ||||||||||
| Operating Lease Liability Noncurrent | $283.0K | $640.0K | $0.00 | $383.0K | $400.0K | $144.0K | |||||||||
| Goodwill | $0.00 | $48.6M | $48.6M | $1.9M | $1.9M | ||||||||||
| Accounts Payable Accrued Expenses And Other Liabilities | $6.7M | $7.8M | -$2.6M | $2.1M | |||||||||||
| Short Term Investments | $110.5M | $119.6M | $46.5M | $0.00 | |||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$800.0K | -$81.2M | $73.5M | $20.1M | $9.4M | ||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $24.0K | $26.0K | -$55.0K | ||||||||||||
| Restricted Cash And Cash Equivalents Noncurrent | $270.0K | $200.0K | $50.0K | ||||||||||||
| Change In Fair Value Of Warrant Liabilities And Fair Value Of Financial Instruments Issued In Excess Of Proceeds | -$30.9M | $76.2M | |||||||||||||
| Accrued Liabilities Current | $5.0M | $3.5M | $2.2M | ||||||||||||
| Issuance Of Common Stock In Connection With Exercise Of Pre Funded Warrants Value | $1.0K | $1.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $35.4M | $50.3M | $58.9M | $20.4M | -$64.2M | -$70.4M | $35.6M | $43.8M | $74.8M | $141.1M | $149.4M | $156.3M | $170.7M | $178.5M | $183.9M | $21.5M | $9.4M | $11.7M | $13.4M | $16.0M | $9.9M | $18.3M | $21.5M | $24.3M | $20.6M | $23.4M | $23.4M | $30.3M | $38.9M | $51.4M | $71.9M | $82.8M | $90.9M | $101.6M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.7M | $5.7M | $8.5M | $6.8M | $26.0M | $5.7M | $3.7M | $40.9M | $46.5M | $65.9M | $70.5M | $76.7M | $94.0M | $101.1M | $108.6M | $114.5M | $8.8M | $11.8M | $10.8M | $13.7M | $13.7M | $16.3M | $19.2M | $22.5M | $19.2M | $22.6M | $635.0K | $2.4M | $937.0K | ||||||||||
| Cash And Cash Equivalents At Carrying Value | $3.7M | $5.7M | $8.5M | $6.8M | $26.0M | $5.7M | $3.7M | $40.9M | $46.5M | $65.9M | $70.5M | $76.7M | $94.0M | $101.1M | $108.6M | $114.5M | $19.1M | $22.5M | $24.4M | $18.6M | $12.2M | $14.3M | $24.0M | $33.2M | $59.1M | $94.2M | $105.5M | $21.2M | $27.0M | $23.1M | |||||||||
| Retained Earnings Accumulated Deficit | -$390.8M | -$373.3M | -$362.1M | -$311.0M | -$387.9M | -$253.5M | -$289.3M | -$279.4M | -$213.6M | -$144.5M | -$134.0M | -$124.8M | -$106.1M | -$96.3M | -$88.9M | -$74.5M | -$68.3M | -$65.8M | -$53.4M | -$50.5M | -$46.5M | -$37.0M | -$33.5M | -$30.3M | -$25.4M | -$22.4M | -$173.3M | -$165.7M | -$156.4M | -$142.9M | -$120.4M | -$108.6M | -$99.6M | -$80.1M | |||||
| Liabilities | $38.8M | $38.9M | $46.7M | $38.5M | $129.0M | $6.0M | $60.5M | $63.0M | $7.5M | $8.5M | $5.3M | $5.1M | $6.4M | $5.8M | $7.8M | $6.1M | $1.1M | $2.0M | $1.9M | $2.2M | $3.5M | $1.6M | $1.5M | $1.6M | $2.4M | $3.4M | $2.5M | $6.5M | $8.0M | $6.3M | $5.7M | $4.7M | $5.8M | $5.4M | |||||
| Common Stock Value | $60.0K | $60.0K | $60.0K | $41.0K | $39.0K | $25.0K | $24.0K | $23.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $1.0K | $19.0K | $16.0K | $13.0K | $13.0K | $9.0K | $9.0K | $9.0K | $9.0K | $7.0K | $7.0K | $23.0K | $1.0K | $23.0K | $23.0K | $23.0K | $23.0K | $22.0K | $22.0K | $22.0K | ||||
| Prepaid Expense And Other Assets Current | $2.9M | $3.8M | $2.8M | $3.3M | $3.6M | $5.1M | $3.4M | $2.2M | $2.4M | $1.7M | $2.3M | $2.6M | $1.5M | $1.4M | $1.7M | $637.0K | $997.0K | $1.1M | $1.5M | $1.5M | $1.3M | $786.0K | $1.9M | $1.5M | $1.9M | $2.3M | $1.2M | $1.6M | $2.3M | $2.7M | $3.8M | $3.6M | $2.2M | $1.3M | |||||
| Liabilities And Stockholders Equity | $129.9M | $144.9M | $161.3M | $114.6M | $120.5M | $80.8M | $96.1M | $106.8M | $82.3M | $149.6M | $154.7M | $161.4M | $177.2M | $184.3M | $191.7M | $192.6M | $10.5M | $13.7M | $15.2M | $18.2M | $13.5M | $19.9M | $23.0M | $25.9M | $23.0M | $26.8M | $25.8M | $36.7M | $46.9M | $57.7M | $77.6M | $87.4M | $96.7M | $107.0M | |||||
| Assets Current | $96.3M | $111.4M | $127.7M | $81.5M | $87.2M | $48.0M | $63.0M | $73.6M | $48.9M | $67.6M | $72.8M | $79.3M | $95.6M | $102.6M | $110.2M | $115.1M | $9.8M | $12.9M | $12.3M | $15.2M | $10.3M | $17.1M | $21.1M | $24.0M | $21.0M | $24.8M | $25.6M | $36.3M | $46.2M | $57.0M | $76.9M | $86.8M | $96.3M | $106.7M | |||||
| Assets | $129.9M | $144.9M | $161.3M | $114.6M | $120.5M | $80.8M | $96.1M | $106.8M | $82.3M | $149.6M | $154.7M | $161.4M | $177.2M | $184.3M | $191.7M | $192.6M | $10.5M | $13.7M | $15.2M | $18.2M | $13.5M | $19.9M | $23.0M | $25.9M | $23.0M | $26.8M | $25.8M | $36.7M | $46.9M | $57.7M | $77.6M | $87.4M | $96.7M | $107.0M | |||||
| Additional Paid In Capital Common Stock | $426.0M | $423.6M | $476.6M | $331.2M | $323.7M | $328.3M | $324.9M | $323.1M | $288.4M | $285.6M | $283.4M | $281.1M | $276.8M | $274.8M | $272.7M | $96.0M | $77.7M | $77.5M | $66.8M | $66.6M | $56.4M | $55.3M | $55.0M | $54.6M | $46.0M | $45.9M | $196.6M | $195.9M | $195.2M | $194.3M | $192.3M | $191.3M | |||||||
| Accounts Payable Current | $4.6M | $5.8M | $2.9M | $5.9M | $2.1M | $1.9M | $465.0K | $2.2M | $2.9M | $3.9M | $1.3M | $1.0M | $1.6M | $857.0K | $1.5M | $758.0K | $150.0K | $741.0K | $256.0K | $753.0K | $480.0K | $751.0K | $706.0K | $449.0K | $189.0K | $374.0K | $276.0K | $886.0K | $1.8M | $1.9M | $1.7M | $1.7M | $3.4M | $2.9M | |||||
| Liabilities Current | $14.3M | $13.7M | $9.2M | $12.5M | $6.0M | $4.2M | $2.9M | $4.9M | $5.5M | $6.3M | $3.3M | $3.0M | $4.0M | $2.7M | $4.2M | $6.1M | $1.1M | $1.9M | $1.7M | $1.9M | $3.2M | $2.3M | $3.2M | $2.4M | $3.9M | $6.3M | $7.8M | $6.2M | $5.7M | $4.6M | $5.8M | $5.4M | |||||||
| Other Assets Noncurrent | $476.0K | $346.0K | $354.0K | $210.0K | $255.0K | $185.0K | $233.0K | $224.0K | $369.0K | $155.0K | $303.0K | $344.0K | $356.0K | $422.0K | $315.0K | $449.0K | $511.0K | $572.0K | $688.0K | $755.0K | $805.0K | $934.0K | $15.0K | $45.0K | $45.0K | $45.0K | $21.0K | ||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$12.1M | $1.0M | -$9.9M | -$8.2M | -$5.6M | $3.0M | -$3.9M | $5.2M | -$482.0K | ||||||||||||||||||||||||||||||
| Accrued Liabilities And Other Liabilities | $9.3M | $7.6M | $6.0M | $6.4M | $3.6M | $2.1M | $2.0M | $2.3M | $2.2M | $2.0M | $1.7M | $1.6M | $2.3M | $1.6M | $2.6M | $4.4M | $269.0K | $953.0K | $1.2M | $1.0M | $2.6M | $762.0K | $522.0K | $742.0K | $1.2M | $1.5M | |||||||||||||
| Operating Lease Right Of Use Asset | $694.0K | $773.0K | $850.0K | $471.0K | $621.0K | $270.0K | $459.0K | $553.0K | $647.0K | $832.0K | $581.0K | $675.0K | $222.0K | $267.0K | $92.0K | $183.0K | $228.0K | $272.0K | $360.0K | $403.0K | $446.0K | ||||||||||||||||||
| Operating Lease Liability Current | $346.0K | $336.0K | $325.0K | $186.0K | $269.0K | $284.0K | $396.0K | $390.0K | $384.0K | $378.0K | $287.0K | $328.0K | $177.0K | $179.0K | $97.0K | $191.0K | $188.0K | $184.0K | $177.0K | $173.0K | $170.0K | ||||||||||||||||||
| Property Plant And Equipment Net | $1.0K | $3.0K | $7.0K | $10.0K | $12.0K | $17.0K | $20.0K | $22.0K | $47.0K | $49.0K | $80.0K | $117.0K | $401.0K | $453.0K | $427.0K | $339.0K | $73.0K | $38.0K | |||||||||||||||||||||
| Amortization Of Operating Lease Asset | $95.0K | $92.0K | $93.0K | $46.0K | $44.0K | $43.0K | |||||||||||||||||||||||||||||||||
| Operating Lease Liability Noncurrent | $376.0K | $467.0K | $555.0K | $315.0K | $386.0K | $83.0K | $184.0K | $284.0K | $461.0K | $299.0K | $350.0K | $45.0K | $90.0K | $48.0K | $97.0K | $191.0K | $236.0K | $281.0K | |||||||||||||||||||||
| Goodwill | $48.6M | $48.6M | $48.6M | $48.6M | $48.6M | $48.6M | $44.5M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | ||||||||||||||||||||||||
| Accounts Payable Accrued Expenses And Other Liabilities | -$2.4M | $451.0K | -$1.0M | -$1.4M | |||||||||||||||||||||||||||||||||||
| Short Term Investments | $89.7M | $101.8M | $116.4M | $71.4M | $57.6M | $37.2M | $55.9M | $30.4M | |||||||||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | $1.2M | -$9.7M | -$11.1M | -$4.7M | |||||||||||||||||||||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $9.0K | -$48.0K | -$18.0K | $102.0K | -$1.0K | $3.0K | $6.0K | -$5.0K | $8.0K | -$2.0K | |||||||||||||||||||||||||||||
| Restricted Cash And Cash Equivalents Noncurrent | $70.0K | $70.0K | $120.0K | $120.0K | $270.0K | $270.0K | $270.0K | $270.0K | $270.0K | $200.0K | $200.0K | ||||||||||||||||||||||||||||
| Change In Fair Value Of Warrant Liabilities And Fair Value Of Financial Instruments Issued In Excess Of Proceeds | -$10.1M | -$96.4M | $31.3M | $13.3M | -$443.0K | $56.2M | |||||||||||||||||||||||||||||||||
| Accrued Liabilities Current | $2.1M | $2.4M | $5.5M | $6.0M | $4.3M | $4.0M | $2.9M | $2.3M | $2.5M | ||||||||||||||||||||||||||||||
| Issuance Of Common Stock In Connection With Exercise Of Pre Funded Warrants Value | $1.0K | $1.0K | $1.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $10.5M | $13.1M | $6.5M | $8.2M | $7.9M | $3.2M | $1.3M | $1.5M | $579.0K | $171.0K | $2.9M | $2.1M | $238.0K | $210.0K |
| Financing Cash Flow * | $53.8M | $133.5M | $33.0M | -$449.0K | $109.6M | $9.7M | $7.6M | $7.9M | $2.9M | $513.0K | $94.8M | $35.6M | $18.8M | |
| Investing Cash Flow * | $10.8M | -$70.3M | -$45.3M | $11.0M | $23.3M | $1.0K | -$40.5M | -$175.0K | -$53.0K | -$8.0K | ||||
| Operating Cash Flow * | -$62.3M | -$47.3M | -$39.5M | -$28.4M | -$28.9M | -$15.2M | -$13.9M | -$11.9M | -$14.9M | -$4.9M | -$41.2M | -$21.1M | -$15.5M | -$9.3M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.2M | -$1.3M | $2.0M | -$654.0K | $2.1M | -$39.0K | -$354.0K | $476.0K | $517.0K | -$65.0K | $958.0K | $1.8M | $190.0K | -$139.0K |
| Increase Decrease In Operating Lease Liability | -$313.0K | -$339.0K | -$363.0K | -$367.0K | -$200.0K | -$180.0K | -$165.0K | |||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $2.1M | $2.1M | -$39.0K | -$1.4M | $1.1M | -$2.0M | -$65.0K | |||||||
| Proceeds From Stock Options Exercised | $230.0K | $215.0K | $1.0K | $71.0K | $37.0K | $464.0K | $16.0K | $215.0K | $4.0K | |||||
| Payments To Acquire Property Plant And Equipment | $9.0K | $565.0K | $25.0K | $23.0K | $8.0K | |||||||||
| Increase Decrease In Accrued Liabilities | -$2.6M | $1.5M | $1.3M | $950.0K | $77.0K | |||||||||
| Increase Decrease In Accounts Payable | -$778.0K | $443.0K | $760.0K | -$759.0K | -$119.0K | |||||||||
| Proceeds From Issuance Of Common Stock | $9.0M | $9.7M | $7.5M | $4.8M | ||||||||||
| Payments To Acquire Available For Sale Securities Debt | $161.1M | $156.1M | $78.3M | |||||||||||
| Proceeds From Sale And Maturity Of Available For Sale Securities | $171.9M | $85.8M | $33.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $2.4M | $2.7M | $2.9M | $1.8M | $3.1M | $1.7M | $1.7M | $1.7M | $1.4M | $2.2M | $2.3M | $2.2M | $2.0M | $2.0M | $1.8M | $878.0K | $197.0K | $437.0K | $227.0K | $627.0K | $211.0K | $237.0K | $404.0K | $161.0K | $106.0K | $646.0K | $992.0K | $1.0M | $804.0K | $606.0K | $634.0K | $1.2M | $250.0K | $90.0K |
| Financing Cash Flow * | $115.0K | $1.0K | -$450.0K | $5.2M | $107.0K | $7.5M | $400.0K | $37.0K | $55.0K | $49.0K | ||||||||||||||||||||||||
| Investing Cash Flow * | $3.9M | $9.8M | $4.3M | -$17.0K | -$45.0K | -$12.0K | ||||||||||||||||||||||||||||
| Operating Cash Flow * | -$16.1M | -$8.7M | -$9.9M | -$8.2M | -$5.2M | -$2.2M | -$4.0M | -$2.3M | -$882.0K | -$9.7M | -$11.1M | -$4.8M | ||||||||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$724.0K | $87.0K | -$471.0K | -$921.0K | $159.0K | -$159.0K | -$103.0K | -$192.0K | -$7.0K | -$521.0K | -$85.0K | $344.0K | ||||||||||||||||||||||
| Increase Decrease In Operating Lease Liability | -$74.0K | -$99.0K | -$78.0K | -$91.0K | -$47.0K | -$43.0K | -$38.0K | |||||||||||||||||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$1.4M | $2.2M | $552.0K | $537.0K | $179.0K | $375.0K | ||||||||||||||||||||||||||||
| Proceeds From Stock Options Exercised | $115.0K | $37.0K | $21.0K | $4.0K | ||||||||||||||||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $17.0K | $45.0K | $12.0K | |||||||||||||||||||||||||||||||
| Increase Decrease In Accrued Liabilities | -$246.0K | -$663.0K | -$1.2M | -$432.0K | ||||||||||||||||||||||||||||||
| Increase Decrease In Accounts Payable | -$154.0K | $678.0K | $2.7M | $798.0K | ||||||||||||||||||||||||||||||
| Proceeds From Issuance Of Common Stock | $107.0K | $7.5M | ||||||||||||||||||||||||||||||||
| Payments To Acquire Available For Sale Securities Debt | $31.9M | $12.9M | ||||||||||||||||||||||||||||||||
| Proceeds From Sale And Maturity Of Available For Sale Securities | $35.7M | $22.7M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.52 | -$0.66 | -$4.73 | -$6.16 | -$2.33 | -$15.72 | -$24.42 | -$1.56 | -$2.30 | -$2.46 | -$2.01 | -$3.60 | -$38.02 | -$31.09 |
| Common Stock Shares Authorized | 300.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 31.5M | 200.0M | 200.0M | 173.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 75.4M | 59.8M | 24.2M | 13.8M | 14.3M | 15.2M | 720.4K | 9.4M | 7.1M | 394.3K | 22.6M | 22.4M | 493.3K | |
| Common Stock Shares Issued | 75.4M | 59.8M | 24.2M | 13.8M | 14.3M | 15.2M | 720.4K | 9.4M | 7.1M | 394.3K | 22.6M | 22.4M | 493.3K | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 14.8M | 1.5M | 655.5K | 9.0M | 4.7M | 382.7K | 22.5M | 6.5M | 416.0K | 311.5K | ||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 44.1M | 5.0M | 5.0M | 0.00 | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Earnings Per Share Basic | $-0.52 | $-0.66 | $-4.73 | $-6.16 | $-2.33 | |||||||||
| Weighted Average Number Of Shares Outstanding Basic | 81.8M | 48.5M | 24.6M | 14.3M | 14.8M | |||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 81.8M | 48.5M | 24.6M | 14.3M | 14.8M | |||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 19.5M | 0.00 | 0.00 | 0.00 | ||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 19.5M | 0.00 | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.21 | -$0.13 | -$0.08 | -$0.28 | -$0.92 | -$0.79 | -$0.33 | -$2.74 | -$0.75 | -$0.73 | -$0.65 | -$0.69 | -$0.66 | -$0.50 | -$0.57 | -$5.51 | -$2.74 | -$8.52 | -$4.01 | -$0.35 | -$0.52 | -$0.37 | -$0.34 | -$0.36 | -$0.43 | -$1.32 | -$0.59 | -$0.17 | -$4.35 | -$2.25 | -$0.51 | -$0.49 | -$0.53 | -$0.40 | -$0.59 | -$0.28 | -$2.71 | -$11.68 | -$9.79 | -$11.23 | -$6.82 | -$12.95 | -$7.20 | ||
| Common Stock Shares Authorized | 300.0M | 300.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 173.0M | 200.0M | |||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||
| Common Stock Shares Outstanding | 59.9M | 59.9M | 59.9M | 41.2M | 38.5M | 24.8M | 23.5M | 23.0M | 13.8M | 13.8M | 13.8M | 13.8M | 14.3M | 14.3M | 14.3M | 1.3M | 19.4M | 16.1M | 13.0M | 13.0M | 9.4M | 9.4M | 9.4M | 9.4M | 6.9M | 6.9M | 22.6M | 22.6M | 22.6M | 22.6M | 22.6M | 22.5M | 22.4M | 21.8M | |||||||||||
| Common Stock Shares Issued | 59.9M | 59.9M | 59.9M | 41.2M | 38.5M | 24.8M | 23.5M | 23.0M | 13.8M | 13.8M | 13.8M | 13.8M | 14.3M | 14.3M | 14.3M | 1.3M | 19.4M | 16.1M | 13.0M | 13.0M | 9.4M | 9.4M | 9.4M | 9.4M | 6.9M | 6.9M | 22.6M | 22.6M | 22.6M | 22.6M | 22.6M | 22.5M | 22.4M | 21.8M | |||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 14.3M | 14.8M | 14.8M | 14.8M | 1.1M | 943.4K | 959.3K | 720.8K | 11.8M | 9.4M | 9.4M | 9.4M | 7.7M | 6.9M | 4.2M | 413.6K | 81.3K | 77.9K | 22.6M | 22.5M | 22.4M | 22.4M | 2.4M | 501.1K | 495.0K | 493.3K | |||||||||||||||||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 10.0K | 5.0M | 5.0M | 10.0K | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | |||||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||
| Earnings Per Share Basic | $-0.21 | $-0.13 | $-0.08 | $1.05 | $-0.92 | $-0.79 | $-0.33 | $-2.74 | $-0.75 | $-0.73 | $-0.65 | $-0.69 | $-0.66 | $-0.50 | |||||||||||||||||||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 77.2M | 77.2M | 77.1M | 51.9M | 42.3M | 30.0M | 30.0M | 24.0M | 14.3M | 14.3M | 14.3M | 14.3M | 14.8M | 14.8M | |||||||||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 77.2M | 77.2M | 77.1M | 55.5M | 42.3M | 30.0M | 30.0M | 24.0M | 14.3M | 14.3M | 14.3M | 14.3M | 14.8M | 14.8M | |||||||||||||||||||||||||||||||
| Preferred Stock Shares Outstanding | 511.00 | 511.00 | 3.8K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||||||||||||
| Preferred Stock Shares Issued | 511.00 | 511.00 | 3.8K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $10.5M | $13.1M | $6.5M | $8.2M | $7.9M | $3.2M | $1.3M | $1.5M | $579.0K | $171.0K | $2.9M | $2.1M | $238.0K | $210.0K |
| Depreciation And Amortization | $5.0K | $9.0K | $11.0K | $22.0K | $35.0K | |||||||||
| Stock Issued During Period Value Stock Options Exercised | $230.0K | $215.0K | $1.0K | $71.0K | $37.0K | $464.0K | $16.0K | $215.0K | $4.0K | |||||
| Depreciation | $171.0K | $109.0K | $21.0K | $10.0K | $9.0K | |||||||||
| Accretion On Investment Discounts | -$1.7M | -$2.8M | -$1.2M | |||||||||||
| Warrants And Rights Outstanding | $11.4M | $44.9M | $76.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.4M | $2.7M | $2.9M | $1.8M | $3.1M | $1.7M | $1.7M | $1.7M | $1.4M | $2.2M | $2.3M | $2.2M | $2.0M | $2.0M | $1.8M | $878.0K | $197.0K | $437.0K | $227.0K | $627.0K | $211.0K | $237.0K | $404.0K | $161.0K | ||||
| Depreciation And Amortization | $2.0K | $2.0K | $3.0K | $4.0K | ||||||||||||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $115.0K | $1.0K | $71.0K | |||||||||||||||||||||||||
| Depreciation | $17.0K | $53.0K | $5.0K | $4.0K | ||||||||||||||||||||||||
| Accretion On Investment Discounts | -$692.0K | -$500.0K | ||||||||||||||||||||||||||
| Warrants And Rights Outstanding | $21.9M | $22.5M | $34.8M | $24.0M | $120.8M | $55.7M | $56.2M |
Most recent annual filing with the SEC: March 19, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.